Pieris Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Using its patented Anticalin® technology, clinical-stage biotechnology business Pieris Pharmaceuticals, Inc. develops unique medications that potentially benefit people with cancer, severe asthma, anaemia, and other medical illnesses with a high unmet medical need. Human proteins called lipocalins that naturally bind, store, and transport a diverse range of chemicals are recombinantly created as anticalins. Almost every target of interest can be virtually bound by our libraries of more than 100 billion unique anticalins.
Pieris Pharmaceuticals has raised $5.0M across 1 funding round on record, the most recent an undisclosed round of $5.0M announced in Jan 2023.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pieris Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Jan 2023.
Pieris Pharmaceuticals Funding Rounds
Pieris Pharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Pieris Pharmaceuticals Funding Compared to Other Biotechnology Startups
Pieris Pharmaceuticals' latest round of $5.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pieris Pharmaceuticals in Biotechnology and Boston
Companies Similar to Pieris Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Pieris Pharmaceuticals Funding FAQs
What does Pieris Pharmaceuticals do?
Using its patented Anticalin® technology, clinical-stage biotechnology business Pieris Pharmaceuticals, Inc. develops unique medications that potentially benefit people with cancer, severe asthma, anaemia, and other medical illnesses with a high unmet medical need. Human proteins called lipocalins that naturally bind, store, and transport a diverse range of chemicals are recombinantly created as anticalins. Almost every target of interest can be virtually bound by our libraries of more than 100 billion unique anticalins.
How much funding has Pieris Pharmaceuticals raised?
Pieris Pharmaceuticals has raised $5.0M across 1 round on record. The most recent is an undisclosed round of $5.0M announced in Jan 2023.
When did Pieris Pharmaceuticals last raise funding?
Pieris Pharmaceuticals' most recent funding round on record is an undisclosed round of $5.0M, announced in Jan 2023.
Who founded Pieris Pharmaceuticals?
FundedIQ lists Arne Skerra (Founder) at Pieris Pharmaceuticals.
Where is Pieris Pharmaceuticals headquartered?
Pieris Pharmaceuticals is based in Boston, Massachusetts, United States.
How many employees does Pieris Pharmaceuticals have?
Pieris Pharmaceuticals is in the 101-250 employee band.
How does Pieris Pharmaceuticals' funding compare to other Biotechnology startups?
Pieris Pharmaceuticals' latest round of $5.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Pieris Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pieris Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.